The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus

Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):182-3. doi: 10.4103/0378-6323.168912.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Female
  • Hepatitis B, Chronic / complications*
  • Hepatitis C, Chronic / complications*
  • Humans
  • Male
  • Pemphigus / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Dermatologic Agents